Browse studies
Find your next paid study
26 recruiting studies matching your filters
Phase 2
Efficacy and Safety of PUL-042 Inhalation Solution in Reducing Lower Respiratory Tract Complications in Patients With Hematologic Malignancies and Recipients of Hematopoietic Stem Cell Transplantation (HSCT) With Documented Viral Infections With PIV, hMPV or RSV
The purpose of this research study is to try to see whether an experimental drug, PUL 042 Inhalation Solution (PUL 042), is effective in reducing the severity …
Hematologic MalignanciesHematopoietic Stem Cell Transplant (HSCT)
Estimated
~$10 – $8,750
Pulmotect, Inc.NCT06665100
Phase 1
A Phase I Study of Safety, Tolerability, Pharmacokinetic and Pharmacodynamics Property of Orally Administered APG-2575 in Patients With Hematologic Malignancies
This is a multi-center, single-agent, open-label, Phase I study of APG-2575. The study consists of the dose escalation stage and the dose expansion stage.
Hematologic Malignancies
Estimated
~$10 – $8,750
Ascentage Pharma Group Inc.NCT03537482